相关实验视频

Updated: Jul 24, 2025

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

抗原性和辅助性共同加强基于自辅助的水凝的个性化细胞疫苗,用于术后癌症疫苗接种

Tao He¹, Yiling Shi², Xiaorong Kou¹

¹Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, PR China.

|July 2, 2023

概括

这项研究介绍了Angel-Vax,一种新的术后癌症疫苗策略. 安吉尔-瓦克斯增强了免疫反应,以防止瘤复发,在与免疫检查点抑制剂相结合时显示出显著的生存益处.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
生物材料科学生物材料科学

背景情况:

术后癌症疫苗旨在预防瘤复发,但面临着低免疫性和有限的癌症抗原的挑战.
目前用于制备术后癌症疫苗的方法通常是复杂和繁的.

研究的目的:

通过共同增强自身瘤细胞的抗原性和辅助性来开发一种"垃圾到宝藏"战略,以增强术后个性化免疫疗法.
创建一种新的癌症疫苗Angel-Vax,具有改进的抗原呈现细胞刺激和成熟能力.

主要方法:

纯化的手术剥皮自主瘤被用作整个抗原谱.
安吉尔-瓦克斯 (Angel-Vax) 的配方是将聚氨酸:聚氨基酸 (pIC) 和免疫性致死瘤细胞封装在由曼南和聚乙烯胺胺组成的自助剂水凝中.
进行了体外和体内研究,以评估Angel-Vax在刺激免疫反应和预防小鼠瘤复发方面的疗效,包括与免疫检查点抑制剂 (ICI) 联合治疗.

主要成果:

与其单个成分相比,Angel-Vax在体外表现出增强的抗原呈现细胞刺激和成熟.
使用Angel-Vax的免疫接种在小鼠中诱导了一种强大的全身细胞毒性T细胞免疫反应,从而导致预防和治疗疗效.
与ICI结合的Angel-Vax联合治疗显著预防了术后瘤复发,与单独ICI相比,平均存活率增加了约35%.

结论:

开发的Angel-Vax战略提供了一种简单且可行的方法来增强术后癌症疫苗的免疫性.
这种方法作为利用各种基于瘤细胞的抗原来抑制术后瘤复发的总体策略具有前景.
安吉尔-瓦克斯在癌症患者的术后免疫治疗中取得了重大进展,改善了治疗结果并降低了复发率.

关键词:

水凝是一种水凝.免疫原性细胞死亡个性化免疫疗法是个性化的免疫疗法.瘤复发的情况这是瘤疫苗.

更多相关视频

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model

Published on: November 28, 2017

相关概念视频

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Vaccinations

Vaccinations

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...